Ultrasound imaging is a commonly used modality for breast cancer detection and diagnosis.
In this review, we summarize ultrasound imaging technologies and their clinical applications …

Breast cancer is a major disease with high morbidity and mortality in women worldwide.
Increased use of imaging biomarkers has been shown to add more information with clinical …

In this analysis, the role of metabolic imaging with fluorine 18 fluorodeoxyglucose (FDG) in
breast cancer is reviewed. The analysis was limited to recent works by using state-of-the-art …

Breast cancer is the most frequent cancer diagnosed in women worldwide. Accurate
baseline staging is necessary to plan optimal breast cancer management. Early detection …

OBJECTIVE. FDG PET/CT affects the management of patients with breast cancer in multiple
settings, including initial staging, treatment response assessment, and evaluation of …

Introduction Hybrid imaging systems providing morphological and functional data in a single
session have been available for oncological imaging for some time. So far, computed …

Purpose Precise staging is needed to plan optimal management in breast cancer. 18F-
fluorodeoxyglucose positron emission tomography coupled with computed tomography …

Positron emission tomography (PET) and computed tomography (CT) complement each
other's strengths in integrated PET/CT. PET is a highly sensitive modality to depict the whole …

The prognosis of patients with locally advanced breast cancer (LABC) remains poor. We
prospectively investigated the impact of 18F-FDG PET/CT at initial staging in this clinical …

Neoadjuvant chemotherapy (NAC) involves administration of chemotherapeutic agents to
patients with newly diagnosed breast cancer prior to definitive surgical treatment …